Weiss Multi-Strategy Advisers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,000
Closed -$248K 150
2023
Q4
$248K Buy
+2,000
New +$204K 0.01% 503
2022
Q1
Sell
-4,000
Closed -$537K 690
2021
Q4
$537K Buy
+4,000
New +$575K 0.01% 542
2021
Q3
Sell
-4,000
Closed -$427K 703
2021
Q2
$427K Buy
+4,000
New +$384K 0.01% 569
2020
Q2
Sell
-9,200
Closed -$619K 557
2020
Q1
$619K Buy
+9,200
New +$572K 0.02% 333
2019
Q4
Sell
-20,000
Closed -$746K 629
2019
Q3
$746K Hold
20,000
0.02% 464
2019
Q2
$749K Buy
+20,000
New +$629K 0.02% 401

Other funds holding DXCM

Weiss Multi-Strategy Advisers's DXCM Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of DexCom (DXCM) in Q1 2024, closing a stake of 7,265 shares — an estimated $902K sold.

Weiss Multi-Strategy Advisers first reported a position in DXCM in Q2 2013 and held it in 43 quarters. The position peaked at $10.2M in Q1 2022. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 7,265 DexCom shares in Q1 2024, an estimated $902K.
  • Weiss Multi-Strategy Advisers first reported a position in DexCom in Q2 2013 and held it in 43 quarters.
  • Weiss Multi-Strategy Advisers's DexCom position peaked at $10.2M in Q1 2022.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.